Bills Pending Delaware Senate Health & Social Services Committee

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
DEHB12EngrossThis Act strengthens the role and responsibilities of the Provider Advisory Board in regard to the implementation and enforcement of The Delaware Child Care Act.
[Detail][Text][Discuss]
2019-03-19
To Senate Health & Social Services Committee
DEHB61EngrossBenzodiazepine drugs that are approved for medical use in the United States are classified by the federal Drug Enforcement Agency as Schedule IV. Fourteen benzodiazepine drugs are currently listed on Schedule IV of the Uniform Controlled Substances A...
[Detail][Text][Discuss]
2019-03-19
To Senate Health & Social Services Committee
DESB34IntroThis Act creates a Prescription Opioid Impact Fund (Fund) through a prescription opioid impact fee (Fee) that is paid by pharmaceutical manufacturer. The anticipated revenue from the Fee is $2.8 million in 2020, $2.7 million in 2021, and $2.5 million...
[Detail][Text][Discuss]
2019-03-12
[Hearing: Mar 27 @ 2:30 pm]
To Senate Health & Social Services Committee
DESB24IntroThis Act allows a patient to qualify for a valid registry identification card to purchase and use medical marijuana for any condition that a physician certifies that medical marijuana would likely provide a therapeutic or palliative benefit. This Act...
[Detail][Text][Discuss]
2019-03-06
[Hearing: Apr 10 @ 2:30 pm]
To Senate Health & Social Services Committee
DESB15IntroThis Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instruct...
[Detail][Text][Discuss]
2019-01-24
[Hearing: Apr 17 @ 2:30 pm]
To Senate Health & Social Services Committee
Syndicate content
feedback